Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Event Logistics

- PMLiVE

Paratek announces positive late-stage results for Nuzyra in bacterial pneumonia

The condition, caused by various bacteria, affects more than 900,000 people in the US every year

- PMLiVE

Q&A with Springer Nature’s Leslie Lansman

Ethical content sharing and the benefits of the CLA Pharmaceutical Licence

- PMLiVE

Missed Origins’ Webinar? Watch How Patient Experience Data is Changing Pharma!

We are thrilled to announce that the recording of our recent webinar, "Patient Data: From data to decisions, maximising the impact of patience experience data in pharma" is now available...

Origins – The Patient Focused Specialists

- PMLiVE

New report now available: Integrating ‘patient first’ into medicine development

A new report has just been published by Cuttsy+Cuttsy that collates all the current best thinking in the ‘patient first’ space, distilling it into a practical and actionable road map...

Cuttsy + Cuttsy

- PMLiVE

J&J’s Tecvayli recommended by NICE to treat relapsed and refractory multiple myeloma

Approximately 5,900 new cases of the blood cancer are diagnosed every year in the UK

- PMLiVE

Boehringer Ingelheim and Brainomix enter fibrosing lung disease partnership

Pulmonary fibrosis, a chronic lung condition, affects up to 20 out of every 100,000 people worldwide

- PMLiVE

LEO Pharma’s delgocitinib cream shows promise in phase 3 chronic hand eczema trials

About 70% of patients with severe cases of the condition report problems performing everyday activities

- PMLiVE

The omnichannel wonderland of opportunities

Picking your omnichannel direction requires a disciplined, scientific approach

- PMLiVE

Always Be in a Growth Mindset: Chief Strategy Officer Christina Hoffman’s Return to Her Education Roots

Medicine is always changing, and the career of Medscape Education’s Chief Strategy Officer, Christina Hoffman, is no exception. The 17-year Medscape veteran recently said goodbye to her role as leader...

Medscape Education

- PMLiVE

FDA establishes rare disease innovation hub to accelerate treatment development

More than 30 million people in the US are currently affected by a rare disease

- PMLiVE

NICE recommends Accord’s oral hormone therapy Orgovyx for advanced prostate cancer

The drug is now the first oral treatment of its kind to be approved by the agency

- PMLiVE

Sanofi/Sobi’s haemophilia A therapy shows ‘highly effective’ bleed protection in children

The rare bleeding disorder affects approximately one in every 5,000 male births annually

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links